Heart Failure /
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Edition: | 1st ed. 2017. |
| Series: | Handbook of Experimental Pharmacology,
243 |
| Subjects: |
Table of Contents:
- Introduction
- Epidemiology
- Clinical trial design, endpoints and regulatory requirements. Biomarkers HFpEF/HFrEF. Imaging Technologies / MRI and Echo. Comorbidities in HF. Current Guideline based therapy of HFreF and HFpEF. New and Emerging Therapies and Targets. Ivabradine
- Beta3 agonists
- Novel MRAs
- pGCs and Natriuretic peptides
- sGC stimulators
- PDE's
- Adenosin and A1 Agonists
- Myosin heavy chain / Troponin
- Stem cells
- Diuretics and Vasopressin
- GeneTherapy
- RNA-based therapies and micro RNAs
- Cardiac myosin activation using gene therapy
- Bendavia - mitochondrial therapies
- WNT signaling
- Anticoagulation therapy and NOACS in HF
- Potassium Binders
- Iron. .